Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
All >

News > Collaborations

Find below news about collaborations, licenses, supplies in Europe and Israel or including organisations from these regions.

Total search results: 4780 | Ordered by Date (descending)
1 2 3 ... 46 47 48  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Boehringer Ingelheim. (1/12/21). "Press Release: Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies". Ingelheim, Oxford & London. 2021-01-12
Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. 2021-01-11
Boehringer Ingelheim. (1/11/21). "Press Release: Quantum Computing. Boehringer Ingelheim and Google Partner for Pharma R&D". Ingelheim & Mountain View, CA. 2021-01-11
Cevec Pharmaceuticals GmbH. (1/8/21). "Press Release: Cevec Announces New License Agreement for Its AAV Manufacturing Technology Elevecta in Gene Therapy". Cologne. 2021-01-08
Merck KGaA. (1/8/21). "Press Release: Merck Announces Formation of Merck Digital Ethics Advisory Panel". Darmstadt. 2021-01-08
Sirion Biotech GmbH. (1/7/21). "Press Release: Sirion Biotech GmbH Licensed Its LentiBoost Transduction Technology to Cellectis". Munich & Cambridge, MA. 2021-01-07
Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. 2021-01-07
CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA. 2021-01-07
Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. 2021-01-06
Ribometrix, Inc.. (1/6/21). "Press Release: Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics". Durham, NC. 2021-01-06
Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA. 2021-01-06
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht. 2021-01-06
ViGeneron GmbH. (1/5/21). "Press Release: ViGeneron Signs Global Collaboration Agreement for Ophthalmic Gene Therapy Development". Munich. 2021-01-05
Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. 2021-01-04
Faron Pharmaceuticals Oy. (1/4/21). "Press Release: Faron to Present at H.C. Wainwright BioConnect". Turku. 2021-01-04
Erytech Pharma. (1/4/21). "Press Release: Erytech to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event". Lyon & Cambridge, MA. 2021-01-04
Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. 2021-01-04
Cytokinetics, Inc.. (12/23/20). "Press Release: Cytokinetics Regains European Rights to Omecamtiv Mecarbil". South San Francisco, CA. 2020-12-23
Veracyte, Inc.. (12/22/20). "Press Release: Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer". Whippany, NJ & San Francisco, CA. 2020-12-22
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz. 2020-12-21
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz. 2020-12-21
Evotec SE. (12/21/20). "Press Release: Evotec Partners with Alloy Therapeutics to Expand Its Antibody Discovery Platform". Hamburg. 2020-12-21
BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz. 2020-12-19
LemnaTec GmbH. (12/18/20). "Press Release: New Distribution Agreement with Polaris Science for Singapore and Malaysia". 2020-12-18
Atomwise, Inc.. (12/18/20). "Press Release: Atomwise and FutuRx Launch A2i Therapeutics – a New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority". San Francisco, CA & Ness Ziona. 2020-12-18
Evotec SE. (12/17/20). "Press Release: Evotec Achieves Key Milestones in Its Collaboration with Bristol Myers Squibb on Targeted Protein Degradation". Hamburg. 2020-12-17
BioNTech SE. (12/16/20). "Press Release: BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine". Mainz & Shanghai. 2020-12-16
Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. 2020-12-15
Novo Holdings A/S. (12/14/20). "Press Release: Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab". Copenhagen. 2020-12-14
ADC Therapeutics S.A.. (12/14/20). "Press Release: ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China 2020-12-14
Roche. (12/9/20). "Press Release: Roche Partners with Moderna to include SARS-CoV-2 Antibody Test in Ongoing COVID-19 Vaccine Trials". Basel. 2020-12-09
Sebia S.A.. (12/9/20). "Press Release: Sebia Enters into License Agreement with Erasmus MC and Radboudumc to Provide Minimal Residual Disease Test from Serum Samples of Multiple Myeloma Patients". Paris. 2020-12-09
RetinAI Medical AG. (12/8/20). "Press Release: RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology". Bern. 2020-12-08
Centogene N.V.. (12/8/20). "Press Release: Centogene and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)". Cambridge, MA, Rostock, Berlin & Munich. 2020-12-08
Boehringer Ingelheim. (12/7/20). "Press Release: Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer". Ingelheim & Vienna. 2020-12-07
Bayer AG. (12/6/20). "Press Release: Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors". Whippany, NJ & South San Francisco, CA. 2020-12-06
Merck KGaA. (12/3/20). "Press Release: Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology". Darmstadt. 2020-12-03
MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon. 2020-12-01
Kaia Health Software GmbH. (11/30/20). "Press Release: Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets". Munich & Parma. 2020-11-30
BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London. 2020-11-25
Grifols S.A.. (11/24/20). "Press Release: Strategic Alliance between Grifols and the Egyptian Government to Boost Plasma-derived Medicines Self-sufficiency in the Middle East and Africa". Barcelona. 2020-11-24
Genmab A/S. (11/24/20). "Press Release: Genmab Announces Enapotamab Vedotin Update. Genmab Will Not Advance the Development of Enapotamab Vedotin". Copenhagen. 2020-11-24
Evotec SE. (11/24/20). "Press Release: Evotec and Rappta Therapeutics Enter Discovery and Development Partnership Focused on Oncology target". Hamburg. 2020-11-24
Novo Holdings A/S. (11/23/20). "Press Release: ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment". Copenhagen. 2020-11-23
Cytokinetics, Inc.. (11/23/20). "Press Release: Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 from Amgen". South San Francisco, CA. 2020-11-23
Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow. 2020-11-23
Novartis AG. (11/19/20). "Press Release: Novartis Secures Exclusive Rights for Potential Acute Respiratory Distress Syndrome Cell Therapy". Basel. 2020-11-19
SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin. 2020-11-19
Evotec SE. (11/17/20). "Press Release: Evotec and Storm Therapeutics Leverage INDiGO Platform to Progress Oncology Project towards Clinical Studies". Hamburg. 2020-11-17
Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases". 2020-11-16
MorphoSys AG. (11/11/20). "Press Release: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab". Monrovia, CA, Planegg & Wilmington, DE. 2020-11-11
MorphoSys AG. (11/11/20). "Press Release: MorphoSys and Cherry Biolabs Announce Licensing of Hemibody Technology". Planegg & Würzburg. 2020-11-11
Cevec Pharmaceuticals GmbH. (11/10/20). "Press Release: Cevec Signs Agreement with Roche for the Use of Cevec’s Elevecta Technology in Gene Therapy". Cologne. 2020-11-10
Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt. 2020-11-09
Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. 2020-11-09
Apeiron Biologics AG. (11/9/20). "Press Release: Apeiron Biologics AG and Domainex Ltd Announce the Expansion of Their Partnership to Progress Targeted Cancer Immune Therapy Drug Discovery". Vienna & Saffron Waldon. 2020-11-09
BioNTech SE. (11/9/20). "Press Release: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study". New York, NY & Mainz. 2020-11-09
PhoreMost Ltd.. (11/9/20). "Press Release: PhoreMost and Oxford Biomedica Enter Gene Therapy Discovery Collaboration". Cambridge & Oxford. 2020-11-09
Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw. 2020-11-05
Robocath S.A.S.. (11/2/20). "Press Release: Robocath Finalizes Creation of the Joint Venture with MicroPort through Its Medical Robotic Subsidiary MedBot". Rouen. 2020-11-02
Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA. 2020-11-02
Oxford BioDynamics plc. (11/2/20). "Press Release: Oxford BioDynamics Announces Strategic Partnership with Boca Biolistics in Order to Advance EpiSwitch Disease Severity Program for COVID-19". Oxford. 2020-11-02
TVM Capital Life Science. (10/27/20). "Press Release: TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, Largest Fund in the Firm’s History ". Munich & Montreal. 2020-10-27
Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. 2020-10-22
ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. 2020-10-20
Cevec Pharmaceuticals GmbH. (10/19/20). "Press Release: Cevec and Rznomics Sign License Agreement for the Use of CAP® Technology in Manufacturing of Adenoviral Vectors". 2020-10-19
Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. 2020-10-15
Rentschler Biopharma SE. (10/14/20). "Press Release: Rentschler Biopharma and ATUM Announce Leap-In Transposase Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins". Laupheim, Milford, MA & Newark, CA. 2020-10-14
Exscientia Ltd.. (10/14/20). "Press Release: Exscientia and Blue Oak Pharmaceuticals Announce Collaboration to Rapidly Discover Innovative Treatments for CNS disorders". 2020-10-14
ERS Genomics Ltd.. (10/14/20). "Press Release: ERS Genomics Announces agreement with Fasmac to Commercialize CRISPR/Cas9 Research Reagents in Japan". Dublin & Kanagawa. 2020-10-14
Iksuda Therapeutics Ltd.. (10/13/20). "Press Release: Iksuda Therapeutics Enters License Agreement with University of Goettingen to Develop a New Generation of Antibody Drug Conjugates". Newcastle. 2020-10-13
Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY. 2020-10-13
Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt. 2020-10-12
Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin. 2020-10-12
Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. 2020-10-09
Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg. 2020-10-08
Rentschler Biopharma SE. (10/7/20). "Press Release: Joining Forces against SARS-CoV-2. Rentschler Biopharma Contributes to Manufacturing of COVID-19 mRNA Vaccine". Laupheim & Milford, MA. 2020-10-07
Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen. 2020-10-06
Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried. 2020-10-06
Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt. 2020-10-06
Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent. 2020-10-06
Bone Therapeutics S.A.. (10/5/20). "Press Release: Bone Therapeutics, Link Health and Pregene to Develop and Commercialize the ALLOB Allogeneic Bone Cell Therapy Platform in China and Southeast Asia". Gosselies. 2020-10-05
Nvidia Corporation. (10/5/20). "Press Release: Nvidia Announces Partnership with GSK’s AI-Powered Lab for Discovery of Medicines and Vaccines". Santa Clara, CA. 2020-10-05
Nvidia Corporation. (10/5/20). "Press Release: Nvidia Building UK’s Most Powerful Supercomputer, Dedicated to AI Research in Healthcare". Santa Clara, CA. 2020-10-05
Vaccibody AS. (10/1/20). "Press Release: Vaccibody Enters into Worldwide License and Collaboration Agreement with Genentech, a Member of the Roche Group, to Develop Individualized Neoantigen Cancer Vaccines". Oslo. 2020-10-01
Numab Therapeutics AG. (9/30/20). "Press Release: Numab Therapeutics Appoints Daniel Vasella as New Chairman of the Board". Wädenswil (Zurich). 2020-09-30
BaseLaunch (BaselArea.swiss). (9/28/20). "Press Release: BaseLaunch Announces that Johnson & Johnson Innovation Has Renewed Its Commitment Becoming Latest Strategic Partner in the Second Phase". Basel. 2020-09-28
Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA. 2020-09-23
Glycotope GmbH. (9/21/20). "Press Release: DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms". Leiden & Berlin. 2020-09-21
BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. 2020-09-17
Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di 2020-09-17
Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. 2020-09-16
Onyx Health. (9/15/20). "Press Release: Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates". 2020-09-15
BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. 2020-09-15
Evotec SE. (9/14/20). "Press Release: Evotec and BIOASTER Partner to Build a Technology and Innovation Hub in Lyon". Hamburg. 2020-09-14
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
Boehringer Ingelheim. (9/11/20). "Press Release: Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia". Ingelheim & New 2020-09-11
Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD. 2020-09-10
Bayer AG. (9/9/20). "Press Release: Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases". Berlin & Salt Lake City, UT. 2020-09-09
Evonetix Ltd.. (9/9/20). "Press Release: Evonetix and Analog Devices Collaborate onThird-Generation DNA Synthesis Platform". Cambridge. 2020-09-09
1 2 3 ... 46 47 48  next pagenext page



Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] Made Without Love 650x80px

» top